Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study

Neurology

Volumn 46, Issue 3, 1996, Pages 678-681

  Laakso, M P ^a   Partanen, K ^a   Riekkinen Jr , P ^a   Lehtovirta, M ^a   Helkala, E L ^a   Hallikainen, M ^a   Hanninen T ^a   Vainio, P ^a   Soininen, H ^a,b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; FEMALE; HIPPOCAMPUS; HUMAN; MALE; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0029982043     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.3.678     Document Type: Article

References (26)

1. Hyman BT, Damasio AR, Van Hoesen GW, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168-1170.
2. Ball MJ, Hachinski V, Fox A, et al. A new definition of Alzheimer's disease: a hippocampal dementia. Lancet 1985;1:14-16.
3. Jack CR Jr, Petersen RC, O'Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-188.
4. Laakso MP, Soininen H, Partanen K, et al. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions. J Neural Transm 1995;9:73-86.
5. Soininen HS, Partanen K, Pitkänen A, et al. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory. Neurology 1994;44:1660-1668.
6. O'Brien JT, Desmond P, Ames D, Schweitzer I, Tuckwell V, Tress B. The differentiation of depression from dementia by temporal lobe magnetic resonance imaging. Psychol Med 1994; 24:633-640.
7. Sulkava R, Wikström J, Aromaa A, et al. Prevalence of severe dementia in Finland. Neurology 1985;35:1025-1029.
8. Skoog I, Nillson L, Palmertz B, Andreasson L-A, Svanborg A. A population based study of dementia in 85-year-olds. N Engl J Med 1993;328:153-158.
9. Mayeux R, Denáro J, Hemenegildo N, et al. A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch Neurol 1992; 49:492-497.
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of NINCDS/ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. revised. Washington, DC: American Psychiatric Association, 1987.
12. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for clinician. J Psychiatry Res 1975;12:189-198.
13. Webster DD. Clinical analysis of the disability on Parkinson's disease. Mod Treat 1968;5:257-262.
14. Rosen WG, Terry RD, Fuld PA, Katzman R, Beck A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;17:486-488.
15. Kritchevsky M, Squire LR. Permanent global amnesia with unknown etiology. Neurology 1993;43:326-332.
16. Golomb J, Kluger A, de Leon MJ, et al. Hippocampal formation size in normal human aging: a correlate of delayed secondary performance. Learn Mem 1994;1:45-54.
17. Petersen RC, Smith G, Kokmen E, Ivnik RJ, Tangalos EG. Memory function in normal aging. Neurology 1992;42:396-401.
18. Howieson DB, Holma LA, Kaye JA, Oken BS, Howieson J. Neurologic function in the optimally healthy oldest old: neuropsychological evaluation. Neurology 1993;43:1882-1886.
19. Mahler ME, Cummings JL. Alzheimer disease and the dementia of Parkinson disease: comparative investigations. Alz Dis Assoc Disord 1990;4:133-149.
20. Rinne JO, Laihinen A, Lonnberg P, Marjamäki P, Rinne UK. A post-mortem study on striatal dopamine receptors in Parkinson's disease. Brain Res 1991;556:117-122.
21. Kerwin JM, Morris CM, Perry RH, Perry EK. Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's disease. Neurosci Lett 1992; 143:101-104.
22. Lange KW, Wells FR, Jenner P, Marsden CD. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease. J Neurochem 1993; 60:197-203.
23. Bancher C, Braak H, Fischer P, Jellinger KA. Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients. Neurosci Lett 1993;162:179-182.
24. Braak H, Braak E, Bohl J. Staging of Alzheimer-related cortical destruction. Eur Neurol 1993;33:403-408.
25. de la Torre JC, Fortin T, Park GAS, et al. Chronic cerebrovascular insufficiency induces dementia-like deficits in aged rats. Brain Res 1992;582:186-195.
26. Wade JPH, Mirsen TR, Hachinski VC, Fisman M, Lau C, Merskey H. The clinical diagnosis of Alzheimer's disease. Arch Neurol 1987;44:24-29.